CIK 0001801170 · Large accelerated filer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sign in to watch- Ticker
- CLOV
- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 981515192
- Phone
- (201) 432-2133
- Business address
- 30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
- Former names
- Social Capital Hedosophia Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,766,493
- in 17 filings, $3.7M under 10b5-1 plans
Net −$3,766,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Toy Andrew −$1.6M Chief Executive Officer sold 4% of stake
- Wai Conrad −$1.5M CEO, Counterpart Health sold 24% of stake
- Reynoso Jamie L. −$204K CEO, Medicare Advantage sold 2% of stake
- Soares Karen −$191K Chief Legal Officer sold 3% of stake
- OLDAKOWSKI JOSEPH FRANK −$118K VP OF FINANCE AND CONTROLLER sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | OLDAKOWSKI JOSEPH FRANK Chief Accounting Officer | Grant or award | +186,403 | 462,300 | ||
| 2026-11-04 | THORNTON JOSEPH CLAY Chief Financial Officer | Grant or award | +328,947 | 1,573,882 | ||
| 2026-10-20 | Soares Karen Chief Legal Officer | Sale 10b5-1 | −19,275 | $4.66 | $90K | 1,573,423 |
| 2026-10-19 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −4,066 | $4.41 | $18K | 2,770,351 |
| 2026-10-15 | Toy Andrew Chief Executive Officer | Sale 10b5-1 | −62,176 | $4.68 | $291K | 9,078,334 |
| 2026-10-15 | Soares Karen Chief Legal Officer | Sale 10b5-1 | −14,673 | $4.68 | $69K | 1,592,698 |
| 2026-10-15 | THORNTON JOSEPH CLAY Interim CFO | Sale 10b5-1 | −4,591 | $4.68 | $21K | 1,244,935 |
| 2026-10-15 | Wai Conrad CEO, Counterpart Health | Sale 10b5-1 | −23,627 | $4.68 | $111K | 1,042,072 |
| 2026-10-15 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −18,273 | $4.68 | $86K | 2,774,417 |
| 2026-10-07 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −2,006 | $4.63 | $9K | 2,792,690 |
| 2026-10-05 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −8,750 | $4.42 | $39K | 2,794,696 |
| 2026-10-01 | Toy Andrew Chief Executive Officer | Sale 10b5-1 | −318,806 | $4.19 | $1.3M | 9,140,510 |
| 2026-09-30 | Miller Brian James Director | Grant or award | +12,481 | 12,481 | ||
| 2026-09-30 | Torricelli Robert G Director | Grant or award | +12,481 | 186,897 | ||
| 2026-09-17 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −1,921 | $4.56 | $9K | 2,803,446 |
| 2026-09-16 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | Sale 10b5-1 | −3,170 | $4.64 | $15K | 275,897 |
| 2026-09-15 | Wai Conrad CEO, Counterpart Health | Sale 10b5-1 | −300,000 | $4.72 | $1.4M | 1,170,056 |
| 2026-09-15 | Soares Karen Chief Legal Officer | Sale 10b5-1 | −6,846 | $4.78 | $33K | 1,607,371 |
| 2026-09-15 | Reynoso Jamie L. CEO, Medicare Advantage | Sale 10b5-1 | −9,273 | $4.78 | $44K | 2,805,367 |
| 2026-09-14 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | Sale | −20,000 | $5.16 | $103K | 279,067 |
Page 1 of 13 · 244 trades